Clinical Trials Logo

Vascular Calcification clinical trials

View clinical trials related to Vascular Calcification.

Filter by:

NCT ID: NCT03758534 Recruiting - Clinical trials for Pseudoxanthoma Elasticum

Natural History of GACI With or Without ARHR2 or PXE

Start date: March 15, 2018
Phase:
Study type: Observational

Generalized arterial calcification of infancy (GACI) is an ultra-rare disorder with an estimated birth prevalence of around 1 in 400,000.1 GACI is generally fatal before birth or within the first six months after birth. The cause of death is frequently myocardial infarction or stroke. GACI is strongly associated with inactivating mutations in ectonucleotide pyrophosphate/ phosphodiesterase 1 (ENPP1). Many patients with GACI, including some without an ENPP1 mutation also present with mutations in adenosine triphosphate binding cassette transporter protein subfamily C member 6 (ABCC6). Autosomal recessive hypophosphatemic rickets type 2 (ARHR2) and pseudoxanthoma elasticum (PXE) are believed to be closely related to GACI. ARHR2 is caused by mutations in the ENPP1 gene and PXE is caused by mutations in the ABCC6 gene, with both being observed among patients with GACI. The natural history of GACI and in particular its long term morbidity and mortality are poorly understood. The primary objective of this study is to characterize overall survival among patients with GACI, over time from birth.

NCT ID: NCT02823093 Recruiting - Clinical trials for Vascular Calcification

Aortic Calcification and Vitamin K Antagonists

AVKAL
Start date: April 2016
Phase: N/A
Study type: Observational

The vitamin K antagonists (VKA) are necessary drugs of prevention and treatment of thrombo-embolic disease. The AVKAL study assesses the impact of VKA treatment on the aortic calcifications development. This is a biomedical research without health product, transversal and monocentric study which compares the aortic calcifications levels of two populations : one treated by VKA and the other which has never been treated by VKA.

NCT ID: NCT01886950 Recruiting - Clinical trials for Chronic Kidney Disease

Evolution of Bone Histomorphometry and Vascular Calcification Before and After Renal Transplantation

Start date: August 1, 2010
Phase: N/A
Study type: Observational

A study of the natural history of bone and mineral disease (BMD) in patients with end-stage renal disease before and after kidney transplantation

NCT ID: NCT01364688 Recruiting - Clinical trials for Vascular Calcification

Oral Alfacalcidol and Coronary Artery Calcification in Predialysis Chronic Kidney Disease

Start date: May 2011
Phase: Phase 2
Study type: Interventional

Active vitamin D at therapeutic dose may prevent vascular calcification but in supraphysiologic dose may precipitate it.

NCT ID: NCT01140490 Recruiting - Hemodialysis Clinical Trials

Sub-total Parathyroidectomy Reduces Vascular Calcification in Haemodialysis Patients

Start date: January 2009
Phase: N/A
Study type: Interventional

The aim of this study was to evaluate whether successful sub-total parathyroidectomy retards cardiovascular calcification in patients with hemodialysis and to investigate the mechanism .